Literature DB >> 23089573

Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.

Lin Li1, Xiaoli Chen, Zuanyu He, Xiaomiao Zhao, Lili Huang, Dongzi Yang.   

Abstract

OBJECTIVES: To explore the clinical and metabolic features exhibited by Chinese adolescents with polycystic ovary syndrome (PCOS) and to determine the differences between nonobese and obese adolescent patients with PCOS.
DESIGN: Clinical cross-sectional study.
SETTING: Department of Gynecology and Reproductive Center. PARTICIPANTS: 25 obese and 66 nonobese adolescents with PCOS and 26 age-matched controls.
INTERVENTIONS: Fasting venous blood samples and an oral glucose tolerance test using 75 g of glucose were obtained from PCOS patients and controls. MAIN OUTCOME MEASURES: Clinical features were summarized. Serum levels of FSH, LH, E(2), TT, SHBG, fasting insulin, and fasting glucose were measured.
RESULTS: The prevalence of obesity in adolescents with PCOS was 27% (25/91). 99% of these patients presented with menstrual disorders, 84% presented with clinical and/or biochemical hyperandrogenism, and 90% exhibited an ultrasonographic appearance of polycystic ovaries. The prevalence of hirsutism and acanthosis nigricans were higher in the obese PCOS group than in the nonobese PCOS group (72% vs 41% and 44% vs 5%, respectively). A total of 5 of 20 obese (25%) and 5 of 36 nonobese patients (14%) demonstrated impaired glucose tolerance levels.
CONCLUSIONS: Chinese adolescents with PCOS manifest clinical and metabolic features similar to those of adult Chinese women with PCOS except for the increased prevalence of hyperandrogenism and insulin resistance. Adolescents with high risk factors, especially those with menstrual disorders and hyperandrogenism, may need careful clinical screening.
Copyright © 2012 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089573     DOI: 10.1016/j.jpag.2012.07.006

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  12 in total

Review 1.  Diagnosis and challenges of polycystic ovary syndrome in adolescence.

Authors:  Sophia E Agapova; Tamara Cameo; Aviva B Sopher; Sharon E Oberfield
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

2.  Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity.

Authors:  Julia Hudnut-Beumler; Jill L Kaar; Anya Taylor; Megan M Kelsey; Kristen J Nadeau; Philip Zeitler; Janet Snell-Bergeon; Laura Pyle; Melanie Cree-Green
Journal:  Pediatr Diabetes       Date:  2021-04-27       Impact factor: 3.409

3.  The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.

Authors:  Reem A Al Khalifah; Iván D Flórez; Brittany Dennis; Binod Neupane; Lehana Thabane; Ereny Bassilious
Journal:  Syst Rev       Date:  2015-09-23

4.  Benefits of short-term structured exercise in non-overweight women with polycystic ovary syndrome: a prospective randomized controlled study.

Authors:  Volkan Turan; Ebru Kaya Mutlu; Ulas Solmaz; Atalay Ekin; Ozge Tosun; Gokhan Tosun; Emre Mat; Cenk Gezer; Mehtap Malkoc
Journal:  J Phys Ther Sci       Date:  2015-07-22

5.  Statistical Genomic Approach Identifies Association between FSHR Polymorphisms and Polycystic Ovary Morphology in Women with Polycystic Ovary Syndrome.

Authors:  Tao Du; Yu Duan; Kaiwen Li; Xiaomiao Zhao; Renmin Ni; Yu Li; Dongzi Yang
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

6.  Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients.

Authors:  Parvin Layegh; Zohreh Mousavi; Donya Farrokh Tehrani; Seyed Mohammad Reza Parizadeh; Mohammad Khajedaluee
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-04

7.  The correlation between serum AMH and HOMA-IR among PCOS phenotypes.

Authors:  Budi Wiweko; Indra Indra; Cynthia Susanto; Muharam Natadisastra; Andon Hestiantoro
Journal:  BMC Res Notes       Date:  2018-02-09

8.  Correlation of anti-Müllerian hormone levels with metabolic syndrome events in polycystic ovary syndrome: A cross-sectional study.

Authors:  Budi Wiweko; Lieke Koes Handayani; Achmad Kemal Harzif; Gita Pratama; Raden Muharam; Andon Hestiantoro; Kanadi Sumapraja
Journal:  Int J Reprod Biomed       Date:  2020-03-29

9.  Hyperinsulinaemic androgen excess in adolescent girls.

Authors:  Lourdes Ibáñez; Ken K Ong; Abel López-Bermejo; David B Dunger; Francis de Zegher
Journal:  Nat Rev Endocrinol       Date:  2014-04-29       Impact factor: 43.330

10.  The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.

Authors:  Fahimeh Ramezani Tehrani; Homeira Rashidi; Mahnaz Bahri Khomami; Maryam Tohidi; Fereidoun Azizi
Journal:  Reprod Biol Endocrinol       Date:  2014-09-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.